- Shares of Galena Biopharma (GALE +3.9%) are enjoying a strong session.
- SA contributor and long-time bull Regarded Solutions is out reiterating a positive outlook for the company going into the new year.
- "GALE should continue to deliver positive results as they proceed in Phase 3 trials of [their] potential legacy drug, NeuVax," the author says, adding that "sales of Abstral could surprise everyone."
Galena Biopharma rallies, SA bull upbeat for 2014
Dec 31 2013, 15:02 ET